Cristina Bernado
Overview
Explore the profile of Cristina Bernado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quintana A, Arenas E, Bernado C, Fernandez Navarro J, Gonzalez J, Esteve-Codina A, et al.
Front Immunol
. 2023 May;
14:1149747.
PMID: 37215143
Introduction: Tumor infiltrating lymphocytes (TILs) are known to be a prognostic and predictive biomarker in breast cancer, particularly in triple negative breast cancer (TNBC) patients. International guidelines have been proposed...
2.
Aran A, Peg V, Rabanal R, Bernado C, Zamora E, Molina E, et al.
Front Immunol
. 2021 Dec;
12:761798.
PMID: 34868006
EBV-specific T cells have been recently described to be involved in fatal encephalitis and myocarditis in cancer patients after immune checkpoint therapies. Here, we report the study of a human...
3.
Triana-Martinez F, Picallos-Rabina P, Da Silva-Alvarez S, Pietrocola F, Llanos S, Rodilla V, et al.
Nat Commun
. 2020 Sep;
11(1):4771.
PMID: 32938939
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
4.
Triana-Martinez F, Picallos-Rabina P, Da Silva-Alvarez S, Pietrocola F, Llanos S, Rodilla V, et al.
Nat Commun
. 2019 Oct;
10(1):4731.
PMID: 31636264
Compounds with specific cytotoxic activity in senescent cells, or senolytics, support the causal involvement of senescence in aging and offer therapeutic interventions. Here we report the identification of Cardiac Glycosides...
5.
Kang S, Guan J, Tan H, Chu T, Thike A, Bernado C, et al.
Clin Cancer Res
. 2018 Dec;
25(8):2588-2600.
PMID: 30593516
Purpose: Trastuzumab-based chemotherapy has shown remarkable clinical benefits for patients with HER2-positive breast cancer. However, treatment regimens involving trastuzumab had little or no effect for a subset of patients. Preliminary...